Cargando…
One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy
Patients with fistulizing inflammatory bowel disease are traditionally difficult to treat. This patient population often experiences delayed or insufficient healing of fistulas using current standard regimens including antibiotics, immunomodulators, anti-tumor necrosis factor-α drug, placement of se...
Autores principales: | Turse, Erica P, Dailey, Francis E, Naseer, Maliha, Partyka, Edward K, Tahan, Veysel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212615/ https://www.ncbi.nlm.nih.gov/pubmed/30397605 http://dx.doi.org/10.12998/wjcc.v6.i12.493 |
Ejemplares similares
-
Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature
por: Turse, Erica P, et al.
Publicado: (2018) -
Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease
por: Dailey, Francis E, et al.
Publicado: (2018) -
Interventions to improve sarcopenia in cirrhosis: A systematic review
por: Naseer, Maliha, et al.
Publicado: (2019) -
Epidemiology, determinants, and management of AIDS cholangiopathy: A review
por: Naseer, Maliha, et al.
Publicado: (2018) -
Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection
por: Basar, Omer, et al.
Publicado: (2021)